Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
-
Published:2019-12-05
Issue:2
Volume:10
Page:198-213
-
ISSN:2159-8274
-
Container-title:Cancer Discovery
-
language:en
-
Short-container-title:Cancer Discov
Author:
Smyth Lillian M.ORCID, Piha-Paul Sarina A., Won Helen H.ORCID, Schram Alison M.ORCID, Saura CristinaORCID, Loi ShereneORCID, Lu Janice, Shapiro Geoffrey I., Juric Dejan, Mayer Ingrid A., Arteaga Carlos L., de la Fuente Macarena I., Brufksy Adam M., Spanggaard Iben, Mau-Sørensen MortenORCID, Arnedos MonicaORCID, Moreno VictorORCID, Boni ValentinaORCID, Sohn Joohyuk, Schwartzberg Lee S., Gonzàlez-Farré XavierORCID, Cervantes AndrésORCID, Bidard François-Clement, Gorelick Alexander N.ORCID, Lanman Richard B.ORCID, Nagy Rebecca J., Ulaner Gary A., Chandarlapaty SaratORCID, Jhaveri Komal, Gavrila Elena I., Zimel Catherine, Selcuklu S. Duygu, Melcer Myra, Samoila Aliaksandra, Cai Yanyan, Scaltriti MaurizioORCID, Mann Grace, Xu Feng, Eli Lisa D., Dujka Melanie, Lalani Alshad S., Bryce Richard, Baselga José, Taylor Barry S., Solit David B., Meric-Bernstam Funda, Hyman David M.
Publisher
American Association for Cancer Research (AACR)
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|